These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 15172046

  • 1. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB.
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [Abstract] [Full Text] [Related]

  • 2. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE.
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [Abstract] [Full Text] [Related]

  • 3. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T, Sumida T.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract] [Full Text] [Related]

  • 4. [Interleukin-1 receptor antagonist anakinra (Kineret) for treatment of rheumatic arthritis].
    Rubbert-Roth A, Perniok A.
    Z Rheumatol; 2003 Aug; 62(4):367-77. PubMed ID: 12928941
    [Abstract] [Full Text] [Related]

  • 5. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Saxne T, Larsson L, Geborek P.
    Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477
    [No Abstract] [Full Text] [Related]

  • 6. Biologics in rheumatoid arthritis.
    Sharma PK, Hota D, Pandhi P.
    J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
    [Abstract] [Full Text] [Related]

  • 7. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis.
    Kary S, Burmester GR.
    Int J Clin Pract; 2003 Apr; 57(3):231-4. PubMed ID: 12723729
    [Abstract] [Full Text] [Related]

  • 8. [New treatments for rheumatoid arthritis].
    Girault V, Flipo RM.
    Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
    [No Abstract] [Full Text] [Related]

  • 9. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
    Prescrire Int; 2004 Apr; 13(70):43-5. PubMed ID: 15148945
    [Abstract] [Full Text] [Related]

  • 10. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ.
    Przegl Lek; 2002 Apr; 59(11):916-8. PubMed ID: 12715722
    [Abstract] [Full Text] [Related]

  • 11. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, 990145 Study Group.
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [Abstract] [Full Text] [Related]

  • 12. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B.
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [Abstract] [Full Text] [Related]

  • 13. Kineret: efficacy and safety in daily clinical practice: an interim analysis of the Kineret response assessment initiative (kreative) protocol.
    Langer HE, Missler-Karger B.
    Int J Clin Pharmacol Res; 2003 Aug; 23(4):119-28. PubMed ID: 15224501
    [Abstract] [Full Text] [Related]

  • 14. Examining the efficacy of biologic therapy: are there real differences?
    Fleischmann RM.
    J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
    [Abstract] [Full Text] [Related]

  • 15. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T.
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract] [Full Text] [Related]

  • 16. Bringing the clinical experience with anakinra to the patient.
    Cohen SB, Rubbert A.
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii36-40. PubMed ID: 12817094
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group.
    Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
    [Abstract] [Full Text] [Related]

  • 18. The role of interleukin-1 in bone resorption in rheumatoid arthritis.
    Strand V, Kavanaugh AF.
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427
    [Abstract] [Full Text] [Related]

  • 19. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM.
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [Abstract] [Full Text] [Related]

  • 20. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Schiff MH.
    Arthritis Rheum; 2005 Jan; 52(1):364-5; author reply 365. PubMed ID: 15641081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.